These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3378 related articles for article (PubMed ID: 6932938)

  • 1. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Stephens TC; Peacock JH
    Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental chemotherapy studies: intercomparison of assays.
    Twentyman PR
    Br J Cancer Suppl; 1980 Apr; 4():279-87. PubMed ID: 7000124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.
    Li XH; Paulus G; Atassi G; Buyssens N
    Am J Pathol; 1984 Jun; 115(3):403-11. PubMed ID: 6731586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice.
    Chu AM; Fowler JF
    Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Povlsen CO; Jacobsen GK
    Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of tumor regrowth to tumor cell survival, tumor cure rates and host survival in a solid tumor model following combined chemotherapy and radiotherapy.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):97-105. PubMed ID: 8054518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
    Laurent G; Atassi G; Hildebrand J
    Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
    Muller PJ; Tator CH; Bloom ML
    Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
    Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA
    Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 169.